On April 9, 2024, Biodesix, Inc. closed the transaction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.39 USD | +4.51% | +3.73% | -24.46% |
May. 21 | Biodesix, Inc. to Present New Data on the Nodify XL2 Test at ATS 2024 Annual Meeting | CI |
May. 13 | TD Cowen Starts Biodesix With Buy Rating, $2.80 Price Target | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.46% | 193M | |
-22.13% | 7.9B | |
+76.82% | 4.53B | |
+8.00% | 2.78B | |
-2.80% | 2.64B | |
-50.41% | 1.99B | |
-17.68% | 1.66B | |
-20.23% | 1.49B | |
+19.61% | 1.23B | |
-45.78% | 1.1B |
- Stock Market
- Equities
- BDSX Stock
- News Biodesix, Inc.
- Biodesix, Inc. announced that it has received $34.999422 million in funding